Skip to main content

Head-to-Head Study of Upadacitinib vs Abatacept in Patients with RA and Inadequate Response to Biologics: Results from SELECT-CHOICE

  • Sponsored by AbbVie US Medical Affairs
Nov 01, 2020 9:00 am
 
 
 
 
 
 
×